Neuron23 logo

Neuron23, Inc.


Neuron23 Stock

Neuron23 is a biotechnology company focused on developing precision medicines for genetically defined neurological and immunological diseases. Neuron23 leverages recent advances in human genetics combined with their state-of-the-art artificial intelligence (AI)-enabled drug discovery and biomarker platforms to advance therapeutics for devastating diseases.

Management Team

Nancy Stagliano CEO, Board Chair
Sam Jackson Chief Medical Officer
Steve Wood SVP Drug Discovery
Arash Rassoulpour SVP Research Operations
Zhonghua Pei SVP Chemistry and DMPK

Funding Information